ProNAi Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.05.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CMPI, SBOW, SRRA, ATRS (PR Newswire)
28.04.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates PLAN, WAVD, SRRA, ATRS (PR Newswire)
18.04.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates VWTR, ATRS, SBOW, SRRA (PR Newswire)
13.04.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates SRRA, ATRS, OBNK (PR Newswire)
13.04.22	Pre-market Movers: ATRS, SRRA, NSTG, RPTX, CFLT… (RTTNews)
18.03.21	ACTengine Program Propels IMTX, Cannabics Pharma On Watch, TBIO Disappoints, All Eyes On PRQR (RTTNews)
23.01.20	CNCE Hits Right Notes, BXRX Faces FDA In Feb., All Eyes On AGTC (RTTNews)
08.12.19	At The ASH 2019 Annual Meeting: AXLA, CBMG, SRRA, EPZM, STOK... (RTTNews)
30.05.18	Sierra Oncology to Present at the Jefferies Global Healthcare Conference in New York (PR Newswire)
30.05.18	Sierra Oncology to Present at the Jefferies Global Healthcare Conference in New York (PR Newswire)
30.05.18	CODX Explodes, AXON Completes Restructuring, No Time To Frown For EOLS (RTTNews)
25.05.18	Les actionnaires de Résolu votent en faveur de l'ensemble des propositions à l'assemblée annuelle (PR Newswire)
10.05.18	Sierra Oncology Reports First Quarter Results (PR Newswire)
10.05.18	Sierra Oncology Reports First Quarter Results (PR Newswire)
17.04.18	Sierra Late-Breaking Data Demonstrating SRA737 Preclinical Activity with PARPi to be Presented at the AACR 2018 Annual Meeting (PR Newswire)
17.04.18	Sierra Late-Breaking Data Demonstrating SRA737 Preclinical Activity with PARPi to be Presented at the AACR 2018 Annual Meeting (PR Newswire)
19.03.18	Sierra Oncology to Present at the Future Leaders in the Biotech Industry Conference in New York (PR Newswire)
19.03.18	Sierra Oncology to Present at the Future Leaders in the Biotech Industry Conference in New York (PR Newswire)
14.03.18	Late-Breaking Abstract Reporting SRA737 Preclinical Activity in CCNE1-Driven and PARPi-Resistant Cancers Accepted for AACR 2018 Annual Meeting (PR Newswire)
14.03.18	Late-Breaking Abstract Reporting SRA737 Preclinical Activity in CCNE1-Driven and PARPi-Resistant Cancers Accepted for AACR 2018 Annual Meeting (PR Newswire)
27.02.18	Sierra Oncology Reports 2017 Year End Results (PR Newswire)
27.02.18	Sierra Oncology Reports 2017 Year End Results (PR Newswire)
27.02.18	Sierra Oncology Significantly Expands Clinical Development Program (PR Newswire)
27.02.18	Sierra Oncology Significantly Expands Clinical Development Program (PR Newswire)
27.02.18	Sierra Oncology and Janssen Sign Supply Agreement for Prostate Cancer Study (PR Newswire)
27.02.18	Sierra Oncology and Janssen Sign Supply Agreement for Prostate Cancer Study (PR Newswire)
21.02.18	Sierra to Report Preclinical Data Demonstrating SRA737 Synergy with PARPi at the AACR 2018 Annual Meeting (PR Newswire)
21.02.18	Sierra to Report Preclinical Data Demonstrating SRA737 Synergy with PARPi at the AACR 2018 Annual Meeting (PR Newswire)
06.02.18	Sierra Oncology to host Program Update in New York on February 27th (PR Newswire)
06.02.18	Sierra Oncology to host Program Update in New York on February 27th (PR Newswire)
29.01.18	Sierra Oncology to Present at the DNA Damage Response Therapeutics Summit (PR Newswire)
29.01.18	Sierra Oncology to Present at the DNA Damage Response Therapeutics Summit (PR Newswire)
03.01.18	Sierra Oncology to Present at the Biotech Showcase in San Francisco (PR Newswire)
03.01.18	Sierra Oncology to Present at the Biotech Showcase in San Francisco (PR Newswire)
28.12.17	INFI Picks Up Steam, HAIR Grows, MRSN Awaits Safety Data, SPPI Advances (RTTNews)
27.12.17	Busy Year Awaits INSY, Agile Not So Energetic, FATE Gathers Steam, SRRA On Watch (RTTNews)
23.12.17	Aireon(SM) System Deployment Passes Midway Point with Fourth Successful Launch (PR Newswire)
21.12.17	Crown Capital Partners Announces $7.0 Million Term Loan with Active Exhaust (PR Newswire)
18.12.17	Airborne Wireless Network Enters into Support Agreement with GE Aviation, A GE Business Unit (PR Newswire)
12.12.17	TSX Venture Exchange Daily Bulletins (PR Newswire)
30.11.17	CIBC Announces Fourth Quarter and Fiscal 2017 Results (PR Newswire)
29.11.17	APEN Gains Steam, SGRY Starting To Heal, AZRX Catches Eyes, No Stopping CPRX (RTTNews)
23.11.17	Cinquième cycle de négociations de l'ALENA - Le ministre Lessard défend les intérêts des entreprises agricoles du Québec à Mexico (PR Newswire)
17.11.17	ACHN Gearing Up For PNH Results, VBLT On Track, WAVE Waxing, Not Waning (RTTNews)
15.11.17	Bureau en Gros veut donner un coup de main au père Noël avec son Centre pour les Fêtes en ligne (PR Newswire)
08.11.17	Sierra Oncology Reports Third Quarter Results (PR Newswire)
08.11.17	Sierra Oncology Reports Third Quarter Results (PR Newswire)
07.11.17	Sierra Oncology to Present at the Jefferies 2017 London Healthcare Conference (PR Newswire)
07.11.17	Sierra Oncology to Present at the Jefferies 2017 London Healthcare Conference (PR Newswire)
30.10.17	More departures between Toronto and Ottawa (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	30.37	2.88 %	K V
Part Grp Hldg	1’330.00	2.39 %	K V
Roche Hldg G	271.80	1.84 %	K V
Givaudan	3’941.00	1.52 %	K V
Novartis	91.64	0.75 %	K V
Geberit	502.80	-0.59 %	K V
CieFinRichemont	139.55	-0.99 %	K V
Swiss Re	133.25	-1.15 %	K V
Zurich Insur Gr	540.00	-1.32 %	K V
Kuehne+Nagel Int	203.00	-2.12 %	K V

Nachrichten zu ProNAi Therapeutics Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten